Literature DB >> 32946885

Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course.

Francisca Leiva-Fernández1, Juan Daniel Prados-Torres2, Alexandra Prados-Torres3, Isabel Del-Cura-González4, Marcos Castillo-Jimena5, Juan Antonio López-Rodríguez6, Maria Eloísa Rogero-Blanco7, Cristina M Lozano-Hernández8, Fernando López-Verde9, María José Bujalance-Zafra10, Maria Victoria Pico-Soler11, Luis Andrés Gimeno-Feliu12, Beatriz Poblador-Plou13, María Teresa Martinez-Cañavate14, Christiane Muth15.   

Abstract

Multimorbidity (MM) is a widespread problem and it poses unsolved issues like the healthcare professionals' training. A training curriculum has been proposed, but it has not been sufficiently explored in a clinical context. The eMULTIPAP course is part of the MULTIPAP complex intervention, applied through a pragmatic controlled, cluster randomized clinical trial to general practitioners (GP) and his/her patients with MM with 12 months follow-up. The eMULTIPAP course is based on problem-based learning, constructivism and Ariadne principles. It has been assessed according to the Kirkpatrick model and has shown knowledge improvement and high applicability of learning with more motivation to consider MM in the clinical practice. It has also improved the Medication Appropriateness Index at 6-months and at 12- months. We conclude that the eMULTIPAP course generates significant changes in GP's learning, enhancing clinical practice in multimorbidity scenarios.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Educational measurement; Inappropriate prescribing; Medical education; Multimorbidity; Polypharmacy; Primary health care; Problem-based learning

Year:  2020        PMID: 32946885     DOI: 10.1016/j.mad.2020.111354

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  4 in total

1.  Use of an Electronic Medication Management Support System in Patients with Polypharmacy in General Practice: A Quantitative Process Evaluation of the AdAM Trial.

Authors:  Robin Brünn; Dorothea Lemke; Jale Basten; Petra Kellermann-Mühlhoff; Juliane Köberlein-Neu; Christiane Muth; Marjan van den Akker
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-17

2.  Identification of the multimorbidity training needs of primary care professionals: Protocol of a survey.

Authors:  Francisca Leiva-Fernández; Alba González-Hevilla; Juan Daniel Prados-Torres; Fuensanta Casas-Galán; Eva García-Domingo; Paula Ortiz-Suárez; Juan Antonio López-Rodríguez; Maria Victoria Pico-Soler
Journal:  J Multimorb Comorb       Date:  2021-06-21

3.  How to Improve Healthcare for Patients with Multimorbidity and Polypharmacy in Primary Care: A Pragmatic Cluster-Randomized Clinical Trial of the MULTIPAP Intervention.

Authors:  Isabel Del Cura-González; Juan A López-Rodríguez; Francisca Leiva-Fernández; Antonio Gimeno-Miguel; Beatriz Poblador-Plou; Fernando López-Verde; Cristina Lozano-Hernández; Victoria Pico-Soler; Mª Josefa Bujalance-Zafra; Luis A Gimeno-Feliu; Mercedes Aza-Pascual-Salcedo; Marisa Rogero-Blanco; Francisca González-Rubio; Francisca García-de-Blas; Elena Polentinos-Castro; Teresa Sanz-Cuesta; Marcos Castillo-Jimena; Marcos Alonso-García; Amaia Calderón-Larrañaga; José M Valderas; Alessandra Marengoni; Christiane Muth; Juan Daniel Prados-Torres; Alexandra Prados-Torres
Journal:  J Pers Med       Date:  2022-05-06

4.  Effectiveness of the MULTIPAP Plus intervention in youngest-old patients with multimorbidity and polypharmacy aimed at improving prescribing practices in primary care: study protocol of a cluster randomized trial.

Authors:  J Daniel Prados-Torres; Alexandra Prados-Torres; Isabel Del Cura-González; Juan A López-Rodríguez; Francisca Leiva-Fernández; Luis A Gimeno-Feliu; Victoria Pico-Soler; Mª Josefa Bujalance-Zafra; Miguel Domínguez-Santaella; Elena Polentinos-Castro; Beatriz Poblador-Plou; Paula Ara-Bardají; Mercedes Aza-Pascual-Salcedo; Marisa Rogero-Blanco; Marcos Castillo-Jiménez; Cristina Lozano-Hernández; Antonio Gimeno-Miguel; Francisca González-Rubio; Rodrigo Medina-García; Alba González-Hevilla; Mario Gil-Conesa; Jesús Martín-Fernández; José M Valderas; Alessandra Marengoni; Christiane Muth
Journal:  Trials       Date:  2022-06-09       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.